American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 4 , Pages 256-260 , July 2009

Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor

  • Sacha Rothschild, MD

      Affiliations

    • Radiation Oncology, Zurich University Hospital, University of Zurich, Zurich, Switzerland
    • Department of Medical Oncology, Bern University Hospital, Bern, Switzerland
    • Corresponding Author InformationCorresponding author. Bern University Hospital, Department of Medical Oncology, 3010 Bern, Switzerland. Tel.: +41 31 632 4116; fax: +41 31 632 4116.
    • ,
  • I. Frank Ciernik, MD

      Affiliations

    • Radiation Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
    • Center for Clinical Research, Zurich University Hospital, University of Zurich, Zurich, Switzerland
    • ,
  • Matthias Hartmann, PhD

      Affiliations

    • Radiation Oncology, Zurich University Hospital, University of Zurich, Zurich, Switzerland
    • ,
  • Bernhard Schuknecht, MD

      Affiliations

    • Neuroradiology, MRI Institute Zurich, Zurich, Switzerland
    • ,
  • Urs M. Lütolf, MD

      Affiliations

    • Radiation Oncology, Zurich University Hospital, University of Zurich, Zurich, Switzerland
    • ,
  • Alexander M. Huber, MD

      Affiliations

    • Otorhinolaryngology, Zurich University Hospital, University of Zurich, Zurich, Switzerland

Received 5 February 2008

References 

  1. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119:568–572
  2. Takahashi K, Yamamoto Y, Sato K, et al. Middle ear carcinoma originating from a primary acquired cholesteatoma: a case report. Otol Neurotol. 2005;26:105–108
  3. Westerman ST, Sylvia LC, Tepper E. Carcinoma arising out of a primary acquired cholesteatoma. J Med Soc N J. 1981;78:600–602
  4. Arriaga M, Curtin H, Takahashi H, et al. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol. 1990;99(9 Pt 1):714–721
  5. National Cancer Institute . National Cancer Institute common toxicity criteria, version 3.0. Bethesda (Mass): National Cancer Institute; 2003;
  6. Nyrop M, Grontved A. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg. 2002;128:834–837
  7. Prasad S, Janecka IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg. 1994;110:270–280
  8. Takano A, Takasaki K, Kumagami H, et al. A case of bilateral middle-ear squamous cell carcinoma. J Laryngol Otol. 2001;115:815–818
  9. Murray EC, Wiltshire CR. Synchronous bilateral middle ear carcinoma. Clin Oncol (R Coll Radiol). 1994;6:57
  10. Suzuki K, Takahashi M, Ito Y, et al. Bilateral middle ear squamous cell carcinoma and clinical review of an additional 5 cases of middle ear carcinomas. Auris Nasus Larynx. 1999;26:33–38
  11. Gillespie MB, Francis HW, Chee N, et al. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg. 2001;127:803–807
  12. Pfreundner L, Schwager K, Willner J, et al. Carcinoma of the external auditory canal and middle ear. Int J Radiat Oncol Biol Phys. 1999;44:777–788
  13. Hahn SS, Kim JA, Goodchild N, et al. Carcinoma of the middle ear and external auditory canal. Int J Radiat Oncol Biol Phys. 1983;9:1003–1007
  14. Lewis JS. Surgical management of tumors of the middle ear and mastoid. J Laryngol Otol. 1983;97:299–311
  15. Moffat DA, Wagstaff SA, Hardy DG. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope. 2005;115:341–347
  16. Dingwell RT, Leslie KE, Sabour P, et al. Influence of the genotype of Staphylococcus aureus, determined by pulsed-field gel electrophoresis, on dry-period elimination of subclinical mastitis in Canadian dairy herds. Can J Vet Res. 2006;70:115–120
  17. Golding-Wood DG, Quiney RE, Cheesman AD. Carcinoma of the ear: retrospective analysis of 61 patients. J Laryngol Otol. 1989;103:653–656
  18. Birzgalis AR, Keith AO, Farrington WT. Radiotherapy in the treatment of middle ear and mastoid carcinoma. Clin Otolaryngol Allied Sci. 1992;17:113–116
  19. Lewis JS. Squamous carcinoma of the ear. Arch Otolaryngol. 1973;97:41–42
  20. Morton RP, Stell PM, Derrick PP. Epidemiology of cancer of the middle ear cleft. Cancer. 1984;53:1612–1617
  21. Moffat DA, Wagstaff SA. Squamous cell carcinoma of the temporal bone. Curr Opin Otolaryngol Head Neck Surg. 2003;11:107–111
  22. Michaels L, Wells M. Squamous cell carcinoma of the middle ear. Clin Otolaryngol Allied Sci. 1980;5:235–248
  23. Kuijpers W, Vennix PP, Peters TA, Ramaekers FC, et al. Acta Otolaryngol. 1996;116:293–298
  24. Bergmann K, Hoppe F, He Y, et al. Human-papillomavirus DNA in cholesteatomas. Int J Cancer. 1994;59:463–466
  25. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19
  26. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–350
  27. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–527
  28. Kojima H, Tanaka Y, Tanaka T, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg. 1998;124:261–264
  29. Holly A, Sittinger M, Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol. 1995;252:366–369
  30. Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol. 2000;21:793–798
  31. Akimoto R, Pawankar R, Yagi T, et al. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec. 2000;62:257–265
  32. Banerjee AR, Jones JL, Birchall JP, et al. Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin. Otol Neurotol. 2001;22:579–581
  33. Albino AP, Reed JA, Bogdany JK, et al. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Am J Otol. 1998;19:30–36
  34. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310
  35. Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci. 2004;25:177–181
  36. Watabe-Rudolph M, Rudolph KL, Averbeck T, et al. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma. Otol Neurotol. 2002;23:793–798
  37. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol. 1996;8:66–71
  38. Ergun S, Carlsoo B, Zheng X. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol Allied Sci. 1999;24:280–285
  39. Desloge RB, Carew JF, Finstad CL, et al. DNA analysis of human cholesteatomas. Am J Otol. 1997;18:155–159

☆ Presented as poster at the 10th Annual Meeting of SASRO (Scientific Association of Swiss Radiation Oncology), March 23–25, 2006, Sion, Switzerland.

PII: S0196-0709(08)00112-9

doi: 10.1016/j.amjoto.2008.06.011

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 4 , Pages 256-260 , July 2009

Article Tools

* Image Usage & Resolution